Back

A placebo-controlled trial of percutaneous coronary intervention for stable angina: the ORBITA-2 trial

1 September 2024 (11:12 - 11:24)
Organised by: Logo
Congress Presentation Part of: The year in review: top trials in coronary interventions impacting guidelines and patient care Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Rasha Al-Lamee

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Microaxial flow pump or standard care in infarct-related cardiogenic shock: the DanGer shock trial
Professor C. Hassager (Copenhagen, DK)
Slides Video
Presentation thumbnail
ILUMIEN IV: optical coherence tomography-guided vs. angiography-guided PCI
Doctor Z. Ali (Roslyn, US)
Slides Video
Presentation thumbnail
Paclitaxel-coated balloon vs. uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomised clinical trial
Doctor R. Yeh (Boston, US)
Slides Video
Presentation thumbnail
The year in review: top trials in coronary interventions impacting guidelines and patient care - discussion
Video

Access the full session

Session thumbnail
The year in review: top trials in coronary interventions impacting guidelines and patient care
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 11:12 CET
You may be interested in
thumbnail
Congress Presentation
How effective is revascularisation for angina? Lessons learnt from the ORBITA trials
thumbnail
Congress Session
The year in review: top trials in coronary interventions impacting guidelines and patient care
thumbnail
Congress Session
Treatment of angina in chronic coronary syndromes: where do we stand?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources